StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | REGN Regeneron | $614.78 | -1.08% | $64.5B | 14.6 | 4.3 | +5.9% | 85.7% | 51 |
| 1 | GILD Gilead Sciences | $134.43 | -1.31% | $166.9B | 18.1 | 5.6 | +3.5% | 79.3% | 66 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $217.72 |
| -0.42% |
| $384.7B |
| 105.8 |
| 6.1 |
| +9.5% |
| 72.0% |
| 61 |
| 3 | AMGN Amgen | $336.79 | +0.09% | $181.8B | 23.3 | 4.9 | +9.1% | 74.0% | 53 |
| 4 | NTRA Natera | $223.37 | +4.41% | $32.0B | — | 12.8 | +36.6% | 65.1% | 50 |
| 5 | ALNY Alnylam Pharmaceuticals | $301.98 | -1.01% | $40.3B | 69.8 | 9.4 | +82.6% | 80.8% | 49 |
| 6 | VRTX Vertex Pharma | $447.54 | -0.10% | $114.6B | 26.4 | 9.4 | +10.1% | 86.2% | 42 |
| 7 | 950220.KQ 950220.KQ | — | — | — | — | — | — | — | — |
| 8 | 950200.KQ 950200.KQ | — | — | — | — | — | — | — | — |
| 9 | RVMD RVMD | $157.48 | +1.84% | $33.5B | — | 2893.2 | — | — | — |